Type(s) of single chemotherapy-Melphalan Posts on Medivizor
Navigation Menu

Type(s) of single chemotherapy-Melphalan Posts on Medivizor

Evaluating long-term outcomes for busulfan, melphalan, and bortezomib for stem cell transplant in multiple myeloma.

Evaluating long-term outcomes for busulfan, melphalan, and bortezomib for stem cell transplant in multiple myeloma.

Posted by on Dec 18, 2020 in Multiple Myeloma | 0 comments

In a nutshell The authors looked at the use of busulfan (Myleran), melphalan (Alkeran), and bortezomib (Velcade) compared with melphalan only for autologous stem cell transplantation (autoSCT) in the treatment of multiple myeloma (MM). The authors concluded that using this drug combination leads to an...

Read More

Looking for patients with relapsed/refractory multiple myeloma to test the safety and effectiveness of isatuximab

Looking for patients with relapsed/refractory multiple myeloma to test the safety and effectiveness of isatuximab

Posted by on Sep 26, 2017 in Multiple Myeloma | 0 comments

In a nutshell This phase 1 clinical trial will test the safety of isatuximab (SAR650984) in patients with relapsed or refractory multiple myeloma, as well as the effectiveness of isatuximab in multiple myeloma patients who have been previously treated with daratumumab (Darzalex). The primary outcome will be measured by side effects and overall...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor